![Cerebral Small Vessel Disease: Neuroimaging Features, Biochemical Markers, Influencing Factors, Pathological Mechanism and Treatment - Frontiers Cerebral Small Vessel Disease: Neuroimaging Features, Biochemical Markers, Influencing Factors, Pathological Mechanism and Treatment - Frontiers](https://www.frontiersin.org/files/MyHome%20Article%20Library/843953/843953_Thumb_400.jpg)
Cerebral Small Vessel Disease: Neuroimaging Features, Biochemical Markers, Influencing Factors, Pathological Mechanism and Treatment - Frontiers
![PDF) Heart type Fatty Acid Binding Protein as a possible marker of traumatic brain injury | Cristina Morganti-Kossmann - Academia.edu PDF) Heart type Fatty Acid Binding Protein as a possible marker of traumatic brain injury | Cristina Morganti-Kossmann - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/69244335/mini_magick20210909-22427-ssajc5.png?1631183377)
PDF) Heart type Fatty Acid Binding Protein as a possible marker of traumatic brain injury | Cristina Morganti-Kossmann - Academia.edu
![A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech | Nature Communications A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-021-23687-8/MediaObjects/41467_2021_23687_Fig1_HTML.png)
A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech | Nature Communications
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study | PLOS Medicine
![Alpha Synuclein Connects the Gut-Brain Axis in Parkinson's Disease Patients – A View on Clinical Aspects, Cellular Pathology and Analytical Methodology | Semantic Scholar Alpha Synuclein Connects the Gut-Brain Axis in Parkinson's Disease Patients – A View on Clinical Aspects, Cellular Pathology and Analytical Methodology | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/67448b2eb564ec8878d55caed12c24a35fdd40cc/3-Figure1-1.png)
Alpha Synuclein Connects the Gut-Brain Axis in Parkinson's Disease Patients – A View on Clinical Aspects, Cellular Pathology and Analytical Methodology | Semantic Scholar
![Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury | Journal of Neurology, Neurosurgery & Psychiatry Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury | Journal of Neurology, Neurosurgery & Psychiatry](https://jnnp.bmj.com/content/jnnp/70/1/95/F2.large.jpg)
Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury | Journal of Neurology, Neurosurgery & Psychiatry
![Frontiers | Biomarkers in Psychiatry: Concept, Definition, Types and Relevance to the Clinical Reality Frontiers | Biomarkers in Psychiatry: Concept, Definition, Types and Relevance to the Clinical Reality](https://www.frontiersin.org/files/Articles/527209/fpsyt-11-00432-HTML/image_m/fpsyt-11-00432-g001.jpg)
Frontiers | Biomarkers in Psychiatry: Concept, Definition, Types and Relevance to the Clinical Reality
![Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid - ScienceDirect Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535947620318570-fx1.jpg)
Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid - ScienceDirect
![Systems-based proteomics to resolve the biology of Alzheimer's disease beyond amyloid and tau | Neuropsychopharmacology Systems-based proteomics to resolve the biology of Alzheimer's disease beyond amyloid and tau | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41386-020-00840-3/MediaObjects/41386_2020_840_Fig1_HTML.png)
Systems-based proteomics to resolve the biology of Alzheimer's disease beyond amyloid and tau | Neuropsychopharmacology
![Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer's disease | Scientific Data Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer's disease | Scientific Data](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41597-021-01054-y/MediaObjects/41597_2021_1054_Fig1_HTML.png)
Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer's disease | Scientific Data
![Transcriptomic signatures of brain regional vulnerability to Parkinson's disease | Communications Biology Transcriptomic signatures of brain regional vulnerability to Parkinson's disease | Communications Biology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs42003-020-0804-9/MediaObjects/42003_2020_804_Fig1_HTML.png)
Transcriptomic signatures of brain regional vulnerability to Parkinson's disease | Communications Biology
![Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease - eBioMedicine Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease - eBioMedicine](https://www.thelancet.com/cms/asset/99b32828-6507-4187-ba6f-6e54975059c4/gr1.jpg)
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease - eBioMedicine
![Cancers | Free Full-Text | Pathological and Molecular Features of Glioblastoma and Its Peritumoral Tissue Cancers | Free Full-Text | Pathological and Molecular Features of Glioblastoma and Its Peritumoral Tissue](https://pub.mdpi-res.com/cancers/cancers-11-00469/article_deploy/html/images/cancers-11-00469-g001.png?1571326594)